Mount Sinai will provide orthopedics, sports medicine, emergency medicine, and musculoskeletal radiology services to world's top tennis stars. The institution has partnered with the USTA for 13 years, promoting health and wellness, preventing injuries, and catering to diverse populations.
The American Academy of Sleep Medicine is hosting Sleep Medicine Disruptors 2025, a biennial event exploring technology innovation and artificial intelligence in sleep health. The event will feature keynote address by Dr. Robert Pearl and award entries for innovative products and services supporting sleep health.
Dr. Machado brings scientific expertise, clinical leadership, and mentorship to the Department of Medicine at UMSOM. He will advance research impact, enhance clinical excellence, and shape the future of academic medicine.
Dr. Andy Jagoda has received the Edward W. Gilmore Lifetime Achievement Award for his significant contributions to emergency medicine education, leadership, and quality improvement. The award recognizes his lifelong commitment to advancing emergency medicine in New York City.
Dr. Gary Ulaner has been elected vice president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), committed to advancing nuclear medicine research and expanding educational activities for professionals. As part of his role, he aims to drive growth and funding for training new radiochemistry and physics professionals.
Heather Jacene, MD, has been elected as the new president-elect of SNMMI, with a focus on strengthening the organization and promoting nuclear medicine. She aims to create opportunities for member participation and multidisciplinary collaborations, while raising awareness of nuclear medicine's value to clinical colleagues and patients.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has selected 7 new Fellows for their exceptional achievements in the field. The SNMMI Fellowship is a prestigious recognition of outstanding service to the society and excellence in scientific discovery, educational efforts, or clinical practice.
Dr. Igho Ofotokun will lead the Department of Medicine at University Hospitals Cleveland Medical Center, focusing on addressing long-term impact of HIV among vulnerable populations. He has authored over 250 scientific publications and holds prestigious awards from Infectious Diseases Society of America.
Dr. Enrico Castillo, an assistant professor of psychiatry at UCLA, has been recognized as an emerging leader in health and medicine scholar by the National Academy of Medicine. He will collaborate with the organization's members over three years to address urgent health challenges.
The American College of Lifestyle Medicine has integrated its first set of lifestyle medicine assessment tools into Epic electronic health records, enabling clinicians to assess patient lifestyle behaviors and readiness for change. The new tools will revolutionize team-based primary care, allowing patients to recognize and make healthi...
Five individuals have been recognized for their exceptional dedication to advancing the field of sleep medicine, with a focus on research, education, advocacy, and clinical care. The award recipients include Dr. Carol Rosen, Dr. Reena Mehra, Dr. Ilene Rosen, Dr. Nathaniel Watson, and Dr. Dennis Hwang.
A recent study found that strict adherence to High-Throughput Sequencing (HTS) technology based carrier screening can achieve high efficiency in preventing severe thalassemia birth defects. The study identified 15.07% of women as carriers of thalassemia and confirmed 59 fetuses with severe thalassemia, all of which were in high-risk co...
Prof Chen brings extensive experience to the role, with a focus on clinically translatable theranostics. He aims to catalyse collaboration and accelerate knowledge exchange in the global nanomedicine community.
A large registry study found that single antiplatelet therapy is associated with lower six-month mortality and major bleeding risk compared to dual antiplatelet therapy after transcatheter aortic valve replacement. This new standard of care may provide better outcomes for high-risk patients with coronary artery disease.
The American College of Chest Physicians has released a new clinical guideline on the transfusion of fresh frozen plasma and platelets in critically ill adults. The guideline contains seven evidence-based recommendations to reduce unnecessary transfusions, which are rarely needed prior to bedside procedures.
Ferhaan Ahmad, a renowned cardiovascular researcher and clinician, has been selected as the new Editor-in-Chief of Circulation: Genomic and Precision Medicine. He brings extensive expertise in cardiovascular genomics and leadership skills to drive scientific advances in the field.
A new study published in Transfusion journal reveals sex-based disparities in the transfusion of whole blood to traumatically injured patients. Women, particularly younger females and those of childbearing potential, are less likely to receive whole blood transfusions compared to men. This disparity is despite whole blood being associa...
Experts call for a transformation in academic medicine to align goals with improving health outcomes, embedding ethics and participation. The BMJ Commission proposes five core principles to guide academic medicine globally.
Researchers at Penn State are developing a next-generation synthetic blood substitute called Nano-RBC, which mimics the shape and movement of human red blood cells. The new blood substitute aims to address the shortage of safe blood sources quickly enough for trauma patients, with potential applications in rural or war-torn areas.
A new study finds that prothrombin concentrate is superior to frozen plasma in controlling bleeding during heart surgery, reducing major bleeding events by nearly 50%. The concentrated product caused fewer adverse effects and saved hospitals resources, suggesting a potential shift in treatment guidelines.
A case study found Bartonella henselae, Babesia odocoilei, and Babesia divergens-like MO-1 DNA in brain tissue samples from a young child with seizures. The presence of these pathogens suggests their potential role in complex neurological illnesses.
The review article examines the relationship between anemia and retinopathy of prematurity, focusing on iron deficiency and underlying molecular mechanisms. Anemia reduces oxygen delivery to the retina, exacerbating hypoxia and promoting pathological neovascularization.
Researchers found that giving plasma, rather than whole blood, improves outcomes in patients with traumatic brain injury (TBI) or shock. Plasma recipients had distinct proteomic profiles associated with later stages of clot formation, neuron survival, and wound repair.
A new study published in BMJ Open finds that supportive workplace culture is crucial for implementing and sustaining lifestyle medicine programs. Synergistic practices such as collaborative groups, visual advertising, and healthy meal options facilitated the adoption of lifestyle medicine programming.
Researchers at HSS present two studies, limiting tourniquet use reduces post-operative pain and opioid consumption, while NSAIDs reduce risk of fibrosis needing further treatment after knee replacement surgery. These findings suggest that reducing tourniquet use can lead to faster recovery with less pain.
Australian Red Cross Lifeblood researchers surveyed over 4,000 people with haemochromatosis and found that their blood and plasma can be used to save lives. The study highlights the potential for these donors to increase blood supplies globally, particularly in countries accepting plasma donations from individuals with this condition.
A recent study investigated hybrid diffuse optics to monitor changes in blood flow and oxygen levels noninvasively. The technology provided detailed insights into how oxygen is delivered and utilized in the body, suggesting improved outcomes for critically ill patients undergoing red blood cell transfusions.
A new study reported that pregnant women with previable premature rupture of membranes (PROM) faced significantly higher risks of severe complications, including sepsis and blood transfusions, after the Texas Senate Bill 8 law went into effect.
A groundbreaking AI model developed by researchers at Emory University accurately predicts the likelihood of blood transfusion in non-traumatic ICU patients, addressing longstanding challenges in predicting transfusion needs. The model achieved exceptional performance metrics, including an AUROC of 0.97 and an accuracy rate of 0.93.
The Human Pangenome Reference Sequencing Project aims to accurately reflect human genetic diversity worldwide. With $14 million in NIH funding, the project will add genomes from an additional 200 individuals to its existing dataset of 550 diverse backgrounds.
Research led by University of Pittsburgh scientists found that exposure to long-wavelength red light reduces blood clots in humans and mice. The study's findings have the potential to reduce deaths and disabilities caused by blood clots worldwide.
A Rutgers-led study of heart-attack patients with anemia found that more liberal blood transfusions can save lives at six months. The analysis combined data from four clinical trials involving 4,311 patients, suggesting a reduced risk of death at six months with more transfusions.
The complimentary CME/CE course, offered in support of the 2022 White House Conference on Hunger, Nutrition and Health, has reported significant improvements in clinicians' knowledge, confidence, and practice of lifestyle medicine. Over 53,000 clinicians have registered for the course so far.
A large trial has found no major difference in clinical outcomes between restrictive and liberal blood transfusion strategies for critically ill patients with aneurysmal subarachnoid hemorrhage. The study suggests that integrating these results with other research can provide a deeper understanding of the optimal threshold.
A large clinical trial found that removing 10% of a patient's blood before major liver surgery reduces the need for transfusions by half. This practice, known as hypovolemic phlebotomy, lowers blood pressure in the liver and is safe, simple, and inexpensive.
The NSF-Piedmont Triad Regenerative Medicine Engine has awarded $2.5 million in grants to six innovative companies to support the commercialization of regenerative medicine products. The funding is expected to catalyze technological advancements, strengthen the local economy, and drive regional competitiveness.
A clinical trial demonstrated the efficacy and tolerability of concizumab, a new drug for haemophilia patients, reducing bleeding rates. Concizumab works by blocking an anticoagulant factor, restoring the delicate balance between clotting and anti-clotting factors.
The American College of Lifestyle Medicine has partnered with the US Space Force to provide lifestyle medicine education, training, and certification to Guardian Resilience Team members. This initiative aims to enhance Space Force service members' health and performance through evidence-based lifestyle interventions.
Researchers report two cases of acquired immune thrombotic thrombocytopenic purpura (TTP) after administration of inactivated COVID-19 vaccine CoronaVac. TTP incidence increased in years following COVID-19 vaccination campaigns, suggesting a possible correlation between the vaccines and the condition.
Roderic Pettigrew, a renowned physician, scientist, and engineer, is recognized for his pioneering work in combining medicine and engineering to advance cardiovascular disease research. His recent achievements include developing the Siemens Cima.X MRI scanner to detect heart disease before it occurs.
Researchers found that community-made videos can effectively encourage Black people to donate blood, with 90% of the target audience stating they would be convinced. The approach leverages emotional engagement and co-design with ethnic minorities to address health inequalities.
Patients with acute brain injury who received a liberal transfusion strategy had a lower risk of unfavorable neurological outcomes compared to those on a restrictive strategy. The study found that anemia was a significant predictor of poor outcomes in these patients.
Researchers found that patients had the same success rate when treated for 24 hours compared to 72 hours, with no difference in need for transfusion, ventilation, or vasopressors. This suggests that shorter octreotide therapy may be sufficient and could help reduce hospital stays and costs.
Red blood cells undergo a regulated process of removal to prevent premature ageing and potential health issues. The study highlights the role of proteins in regulating this process, paving the way for novel therapeutics and early diagnostics for anaemia.
The new journal aims to promote and lead the development of disciplines with cutting-edge scientific research on food and medicine homology. It focuses on how various foods can provide benefits beyond just satisfying hunger, from nutritional support to therapeutic effects.
A 20-year multicenter study found improvements in gender parity and career trends among internal medicine chief residents, with a significant increase in female participation and a rise in pursuing hospital medicine careers. The study also revealed new roles such as quality improvement and patient safety chief residents.
Results of a Phase 2 clinical trial show that nipocalimab can delay or prevent anemia and intrauterine blood transfusions in babies at high risk for Hemolytic Disease of the Fetus and Newborn (HDFN). The study involved 13 pregnant women who received intravenous nipocalimab between 14 and 35 weeks of gestation.
A clinical study in Birmingham has found that nipocalimab can improve the survival rate of unborn babies with rare fetal anaemia. The majority of pregnant patients who received nipocalimab gave birth at or after 32 weeks without needing an intrauterine transfusion, resulting in a perinatal survival rate of 92%.
Researchers at Karolinska Institutet have conducted a Phase 2 UNITY clinical trial involving pregnant women with a history of very severe HDFN. Nipocalimab was found to prevent and mitigate the disease without causing serious side effects in the mother or fetus.
β-Thalassemia patients experience iron overload due to increased intestinal absorption and transfusions, leading to oxidative stress and tissue damage. Chelation therapy is the cornerstone of treatment, but novel therapeutic strategies are needed to optimize patient outcomes.
A pilot study found evidence of human co-infections with Bartonella and Babesia odocoilei in six out of seven patients with chronic, non-specific illness. The discovery could lead to better diagnoses and treatments for patients with these infections.
Researchers found that WIC enrollment was associated with lower rates of gestational diabetes, preterm birth, blood transfusions, and ICU admissions. This suggests that programs like WIC can improve pregnancy health.
Researchers developed a new 50 L bioreactor design to improve platelet production from iPS cells. The larger tank showed lower efficiencies and poorer quality platelets due to non-optimized turbulent flow, but the team found a solution by simulating a three-level impeller system.
A new study found that a liberal blood transfusion strategy may improve outcomes for patients with traumatic brain injury, leading to better functional independence and quality of life. Six months after the injury, patients who received more frequent blood transfusions showed higher levels of recovery and improved quality of life compa...
Julie Dawn Bolin, a seasoned nuclear medicine technologist and educator, has been elected as the new president of the SNMMI Technologist Section for 2024-25. Bolin aims to advance the field by bolstering educational initiatives, championing advocacy efforts, and promoting access to education and healthcare in marginalized communities.
A world-first study published in Nature Medicine has found that precision medicine outperforms standard therapy in treating high-risk childhood cancer. The study showed a staggering 55% of children achieved complete or partial remission after receiving personalized treatment.
Irina Petrache, MD, has commenced her term as President of the American Thoracic Society. She was announced at the ATS 2024 International Conference and is a professor of medicine at National Jewish Health and University of Colorado.
A team led by Massachusetts General Hospital used a new drug to save the life of a patient with immune thrombotic thrombocytopenic purpura (iTTP), a rare disorder characterized by uncontrolled clotting. The drug, recombinant ADAMTS13, reversed the disease process in a patient with an extremely severe form of iTTP.
The AASM has announced five 2024 award recipients, including Dr. Michael Littner, Dr. Shahrokh Javaheri, Dr. Iris Perez, Lynne Lamberg, and Dr. Lisa Wolfe, for their significant contributions to research, education, advocacy, and clinical care in sleep medicine.
A new research commentary highlights AI's potential uses in sleep medicine for clinical applications, lifestyle management, and population health. The committee also reviewed barriers and challenges associated with using AI-enabled technologies.